Dyslipidémie
Éducation
%20(1).png)
Vidéo éducative sur le carcinome épidermoïde cutané : Docteur Rauh - oncologue médical CHEM Luxembourg
.jpg/jcr:content/image%20(24).jpg)
.jpg/jcr:content/image%20(81).jpg)
Understanding Cardiovascular Risk and Prevention: Insights from Professor Pasquale Perrone-Filardi
A phase III randomized trial evaluating alirocumab 300 mg every 4 weeks as monotherapy or add-on to statin: ODYSSEY CHOICE I
Roth Eli M et al. Atherosclerosis vol. 254 (2016): 254-262
